# OnCo record nct06908772 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06908772/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06908772", "NCT06908772" ;
  schema:name "Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients"@en ;
  schema:description "A phase 2/3 trial in lung cancer, run by Shanghai JMT-Bio Inc., not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06908772/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06908772> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/egfr-mutant-nsclc/>, <https://onco.cc/cancers/met-altered-nsclc/> .